Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Telix
Telix
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Illuccix
Gallium
2021-12-17
Positron-emission tomography
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
healthy volunteers/patients
Girentuximab
renal cell carcinoma
,
recurrence
,
clear cell adenocarcinoma
,
adenomyoepithelioma
,
kidney neoplasms
,
carcinoma
,
colorectal neoplasms
,
pancreatic ductal carcinoma
,
non-small-cell lung carcinoma
,
hepatocellular carcinoma
,
stomach neoplasms
,
esophageal neoplasms
,
nasopharyngeal carcinoma
,
lung neoplasms
,
sarcoma
,
glioblastoma
,
squamous cell carcinoma of head and neck
,
liver neoplasms
,
uterine cervical neoplasms
,
small cell lung carcinoma
,
cholangiocarcinoma
,
ovarian epithelial carcinoma
,
nasopharyngeal neoplasms
Phenylalanine
glioblastoma
Riboprine
hypertriglyceridemia
,
schizophrenia
,
psychotic disorders
,
mental disorders
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
Fludeoxyglucose f-18
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
healthy volunteers/patients
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
mouth neoplasms
,
cardiovascular diseases
,
atherosclerosis
,
vascular diseases
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
esophageal squamous cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use